ClinicalTrials.govpublic full text
An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...
prostate cancer, breast cancer, lung cancer, colorectal cancer, head and neck cancer, immunotherapy, prostate, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 837455
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.